Results 351 to 360 of about 2,974,682 (398)
Some of the next articles are maybe not open access.

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

An oral phosphodiesterase inhibitor (apremilast) for inflammatory rosacea in adults: a pilot study.

JAMA dermatology, 2014
B. Thompson   +4 more
semanticscholar   +1 more source

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors   +2 more
exaly  

Phosphodiesterase Inhibitors

2010
R. Hamish McAllister-Williams   +199 more
openaire   +1 more source

Phosphodiesterase Inhibitor Effect on Small Artery Function in Preeclampsia

Hypertension in Pregnancy, 2011
R. Samangaya   +3 more
semanticscholar   +1 more source

Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia.

Journal of Medicinal Chemistry, 2014
J. Bartolomé-Nebreda   +13 more
semanticscholar   +1 more source

A review of cilostazol, a phosphodiesterase inhibitor, and its role in preventing both coronary and peripheral arterial restenosis following endovascular therapy.

Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery), 2009
S. Dindyal, C. Kyriakides
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy